Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Ponatinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Bosutinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Sunitinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
10-hydroxyusambarensine
Potential treatment - theoretical effect Natural product Antiviral Sep/02/2021
hACE21−740-Fc
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2021
scFv-IL6R-Fc
Potential treatment - theoretical effect Experimental Other treatment Jun/11/2021
Ruxolitinib
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021
Acetylsalicylic acid
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
IVIg
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Interferon alfa
Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021
Interferon beta
Potential treatment - theoretical effect Used to treat other disease Antiviral May/12/2021
rlcv-miR-rL1-28-3p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
aly-miR396a-5p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
Astemizole
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2021
VH-Fc ab8
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
IgG1 ab1
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
6D3
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
Sarilumab 
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/29/2021
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
GC376
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021